Functional Roles of Fatty Acids and Their Effects on Human Health.
暂无分享,去创建一个
[1] N. Flamand,et al. Regulation of inflammation by cannabinoids, the endocannabinoids 2‐arachidonoyl‐glycerol and arachidonoyl‐ethanolamide, and their metabolites , 2015, Journal of leukocyte biology.
[2] E. Voest,et al. Increased Plasma Levels of Chemoresistance-Inducing Fatty Acid 16:4(n-3) After Consumption of Fish and Fish Oil. , 2015, JAMA oncology.
[3] P. Calder. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. , 2015, Biochimica et biophysica acta.
[4] P. Calder,et al. n-3 Long-chain PUFAs reduce respiratory morbidity caused by iron supplementation in iron-deficient South African schoolchildren: a randomized, double-blind, placebo-controlled intervention. , 2015, The American journal of clinical nutrition.
[5] J. Chardigny,et al. Is there a linear relationship between the dose of ruminant trans-fatty acids and cardiovascular risk markers in healthy subjects: results from a systematic review and meta-regression of randomised clinical trials , 2014, British Journal of Nutrition.
[6] P. Calder. Very long chain omega‐3 (n‐3) fatty acids and human health , 2014 .
[7] L. Schwingshackl,et al. Monounsaturated fatty acids, olive oil and health status: a systematic review and meta-analysis of cohort studies , 2014, Lipids in Health and Disease.
[8] Albert Koulman,et al. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study , 2014, The lancet. Diabetes & endocrinology.
[9] D. Mozaffarian,et al. Plasma Phospholipid Trans‐Fatty Acids Levels, Cardiovascular Diseases, and Total Mortality: The Cardiovascular Health Study , 2014, Journal of the American Heart Association.
[10] J. Dai,et al. Effects of Omega-3 fatty acid on major cardiovascular events and mortality in patients with coronary heart disease: a meta-analysis of randomized controlled trials. , 2014, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[11] Simon G Thompson,et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. , 2014, Annals of internal medicine.
[12] D. Alexander,et al. Long-Chain Omega-3 Fatty Acids Eicosapentaenoic Acid and Docosahexaenoic Acid and Blood Pressure: A Meta-Analysis of Randomized Controlled Trials , 2014, American journal of hypertension.
[13] R. Sandhoff,et al. Ceramide synthesis in the epidermis. , 2014, Biochimica et biophysica acta.
[14] P. Calder,et al. Omega-6 and omega-3 polyunsaturated fatty acids and allergic diseases in infancy and childhood. , 2014, Current pharmaceutical design.
[15] Ann-Hwee Lee,et al. Transcriptional Control of Hepatic Lipid Metabolism by SREBP and ChREBP , 2013, Seminars in Liver Disease.
[16] G. Corrao,et al. Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected]. , 2013, Atherosclerosis Supplements.
[17] N. Parekh,et al. Dietary fat in breast cancer survival. , 2013, Annual review of nutrition.
[18] F. Velotti,et al. Dietary ω-3 Polyunsaturated Fatty Acid DHA: A Potential Adjuvant in the Treatment of Cancer , 2013, BioMed research international.
[19] M. Roncaglioni,et al. n-3 fatty acids in patients with multiple cardiovascular risk factors. , 2013, The New England journal of medicine.
[20] Xiao-ying Li,et al. Short-term effects of fish-oil supplementation on heart rate variability in humans: a meta-analysis of randomized controlled trials. , 2013, The American journal of clinical nutrition.
[21] C. Peterson,et al. Omega-3 Fatty Acids Reduce Adipose Tissue Macrophages in Human Subjects With Insulin Resistance , 2013, Diabetes.
[22] Dolores Corella,et al. Primary prevention of cardiovascular disease with a Mediterranean diet. , 2013, The New England journal of medicine.
[23] P. Lewandowski,et al. Marine polyunsaturated fatty acids and cancer therapy , 2013, British Journal of Cancer.
[24] An Pan,et al. α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. , 2012, The American journal of clinical nutrition.
[25] M. Krebs,et al. Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial. , 2012, The American journal of clinical nutrition.
[26] V. Perkovic,et al. Omega 3 Fatty Acids and Cardiovascular Outcomes: Systematic Review and Meta-Analysis , 2012, Circulation. Cardiovascular quality and outcomes.
[27] E. Ntzani,et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. , 2012, JAMA.
[28] S. Yusuf,et al. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. , 2012, The New England journal of medicine.
[29] E. Riboli,et al. Plasma Phospholipid Fatty Acid Concentration and Incident Coronary Heart Disease in Men and Women: The EPIC-Norfolk Prospective Study , 2012, PLoS medicine.
[30] Huan Wang,et al. Palmitoleate Induces Hepatic Steatosis but Suppresses Liver Inflammatory Response in Mice , 2012, PloS one.
[31] P. Calder,et al. Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis , 2012, British Journal of Nutrition.
[32] H. Perera,et al. Combined ω3 and ω6 Supplementation in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Refractory to Methylphenidate Treatment , 2012, Journal of child neurology.
[33] M. Gerber. Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies , 2012, British Journal of Nutrition.
[34] H. Seo,et al. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. , 2012, Archives of internal medicine.
[35] W. Harris,et al. Fish oil -- how does it reduce plasma triglycerides? , 2012, Biochimica et biophysica acta.
[36] J. Buckley,et al. Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial. , 2012, Nutrition.
[37] C. Ulrich,et al. Fatigue, inflammation, and ω-3 and ω-6 fatty acid intake among breast cancer survivors. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] T. Kadowaki,et al. Saturated fatty acid and TLR signaling link β cell dysfunction and islet inflammation. , 2012, Cell metabolism.
[39] M. Koshiba,et al. Effects of Large Doses of Arachidonic Acid Added to Docosahexaenoic Acid on Social Impairment in Individuals With Autism Spectrum Disorders: A Double-Blind, Placebo-Controlled, Randomized Trial , 2012, Journal of clinical psychopharmacology.
[40] P. Calder. Mechanisms of action of (n-3) fatty acids. , 2012, The Journal of nutrition.
[41] E. Smit,et al. Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT , 2012, European Journal of Clinical Nutrition.
[42] K. Clément,et al. Dietary factors and low-grade inflammation in relation to overweight and obesity , 2011, British Journal of Nutrition.
[43] R. Medema,et al. Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids. , 2011, Cancer cell.
[44] T. Reiman,et al. Supplementation with fish oil increases first‐line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer , 2011, Cancer.
[45] M. Ferguson,et al. Lean body mass gain in patients with head and neck squamous cell cancer treated perioperatively with a protein‐ and energy‐dense nutritional supplement containing eicosapentaenoic acid , 2011, Head and Neck.
[46] K. Swedberg. n-3 Fatty acids in cardiovascular disease. , 2011, The New England journal of medicine.
[47] Christine M. Williams,et al. Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome—LIPGENE: a European randomized dietary intervention study , 2011, International Journal of Obesity.
[48] J. Hibbeln,et al. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. , 2011, The American journal of clinical nutrition.
[49] T. Reiman,et al. Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy , 2011, Cancer.
[50] S. López,et al. Oleic acid in olive oil: from a metabolic framework toward a clinical perspective. , 2011, Current pharmaceutical design.
[51] P. Pérez-Martínez,et al. Mediterranean diet rich in olive oil and obesity, metabolic syndrome and diabetes mellitus. , 2011, Current pharmaceutical design.
[52] K. Wittkowski,et al. Algal docosahexaenoic acid affects plasma lipoprotein particle size distribution in overweight and obese adults. , 2011, The Journal of nutrition.
[53] P. Toth. GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects , 2011 .
[54] M. Garg,et al. Docosapentaenoic acid (22:5n-3): a review of its biological effects. , 2011, Progress in lipid research.
[55] John M. Davis,et al. n-6 Fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials , 2010, British Journal of Nutrition.
[56] P. Galan,et al. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial , 2010, BMJ : British Medical Journal.
[57] G. Steinbeck,et al. OMEGA, a Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial Infarction , 2010, Circulation.
[58] J. Geleijnse,et al. n-3 fatty acids and cardiovascular events after myocardial infarction. , 2010, The New England journal of medicine.
[59] Kai Simons,et al. Revitalizing membrane rafts: new tools and insights , 2010, Nature Reviews Molecular Cell Biology.
[60] B. Strandvik,et al. EPA supplementation improves teacher rated behaviour and oppositional symptoms in children with ADHD Short title : RCT of EPA in ADHD , 2011 .
[61] P. Calder,et al. Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. , 2010, Atherosclerosis.
[62] A. Zampelas. Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. , 2010, Atherosclerosis.
[63] M. Chatfield,et al. Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial1234 , 2010, The American journal of clinical nutrition.
[64] P. Calder,et al. Cardiovascular effects of marine omega-3 fatty acids , 2010, The Lancet.
[65] P. Calder,et al. The effect of three lipid emulsions differing in fatty acid composition on growth, apoptosis and cell cycle arrest in the HT-29 colorectal cancer cell line. , 2010, Clinical nutrition.
[66] S. Czernichow,et al. n-6 Fatty acids and cardiovascular health: a review of the evidence for dietary intake recommendations , 2010, British Journal of Nutrition.
[67] B. Baune,et al. Review: Hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis , 2010, Therapeutic advances in endocrinology and metabolism.
[68] J. Ntambi,et al. Genetic control of de novo lipogenesis: role in diet-induced obesity , 2010, Critical reviews in biochemistry and molecular biology.
[69] P. Kogner,et al. Omega-3 fatty acids in cancer, the protectors of good and the killers of evil? , 2010, Experimental cell research.
[70] D. Mozaffarian,et al. Effects on Coronary Heart Disease of Increasing Polyunsaturated Fat in Place of Saturated Fat: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2010, PLoS medicine.
[71] R. DuBois,et al. Eicosanoids and cancer , 2010, Nature Reviews Cancer.
[72] F. Hu,et al. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. , 2010, The American journal of clinical nutrition.
[73] F. Schick,et al. Circulating Palmitoleate Strongly and Independently Predicts Insulin Sensitivity in Humans , 2009, Diabetes Care.
[74] N. Samani,et al. Saturated Fatty Acids Do Not Directly Stimulate Toll-Like Receptor Signaling , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[75] F. Kim,et al. Activation of NF-&kgr;B by Palmitate in Endothelial Cells: A Key Role for NADPH Oxidase-Derived Superoxide in Response to TLR4 Activation , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[76] A. Choi,et al. Fatty Acids Modulate Toll-like Receptor 4 Activation through Regulation of Receptor Dimerization and Recruitment into Lipid Rafts in a Reactive Oxygen Species-dependent Manner* , 2009, The Journal of Biological Chemistry.
[77] S. Egert,et al. Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans. , 2009, The Journal of nutrition.
[78] W. Willett,et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. , 2009, The American journal of clinical nutrition.
[79] P. Calder,et al. Fish oil n-3 polyunsaturated fatty acids selectively affect plasma cytokines and decrease illness in Thai schoolchildren: a randomized, double-blind, placebo-controlled intervention trial. , 2009, The Journal of pediatrics.
[80] E. Levy,et al. Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study. , 2009, Paediatrics & child health.
[81] A. Verhoeven,et al. Activation of Hepatic Lipase Expression by Oleic Acid: Possible Involvement of USF1 , 2009, Nutrients.
[82] Walter C Willett,et al. Dietary fats and prevention of type 2 diabetes. , 2009, Progress in lipid research.
[83] M. Dorgan,et al. Effect of fish oil on arrhythmias and mortality: systematic review , 2008, BMJ : British Medical Journal.
[84] Gissi-Hf Investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.
[85] S. Watkins,et al. Identification of a Lipokine, a Lipid Hormone Linking Adipose Tissue to Systemic Metabolism , 2008, Cell.
[86] N. Meguid,et al. Role of polyunsaturated fatty acids in the management of Egyptian children with autism. , 2008, Clinical biochemistry.
[87] D. Jump. N-3 polyunsaturated fatty acid regulation of hepatic gene transcription , 2008, Current opinion in lipidology.
[88] S. Basu,et al. Serum fatty acid composition and indices of stearoyl-CoA desaturase activity are associated with systemic inflammation : longitudinal analyses in middle-aged men , 2008, British Journal of Nutrition.
[89] U. Risérus. Fatty acids and insulin sensitivity , 2008, Current opinion in clinical nutrition and metabolic care.
[90] W. Harris,et al. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. , 2008, Atherosclerosis.
[91] L. Tavazzi,et al. ect of n-3 polyunsaturated fatty acids in patients with chronic heart failure ( the GISSI-HF trial ) : a randomised , double-blind , placebo-controlled trial , 1980 .
[92] L. Cerchietti,et al. Effects of Eicosapentaenoic and Docosahexaenoic n-3 Fatty Acids From Fish Oil and Preferential Cox-2 Inhibition on Systemic Syndromes in Patients With Advanced Lung Cancer , 2007, Nutrition and cancer.
[93] C. Albert,et al. Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office Of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmogenesis Workshop. , 2007, Circulation.
[94] P. Sorgi,et al. Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder , 2007, Nutrition journal.
[95] Y. Matsuzawa,et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis , 2007, The Lancet.
[96] M. Guarcello,et al. EPA-enriched oral nutritional support in patients with lung cancer: effects on nutritional status and quality of life , 2007 .
[97] A. Farmer,et al. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes , 2007, Diabetologia.
[98] J. Lau,et al. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. , 2006, Atherosclerosis.
[99] G. Murray,et al. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[100] R. Mensink,et al. Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio. , 2006, The American journal of clinical nutrition.
[101] Ethan M Balk,et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. , 2006, The American journal of clinical nutrition.
[102] P. Calder,et al. Dietary α-linolenic acid and health-related outcomes: a metabolic perspective , 2006, Nutrition Research Reviews.
[103] R. Deckelbaum,et al. n-3 fatty acids and gene expression. , 2006, The American journal of clinical nutrition.
[104] R. Deschenes,et al. Thematic review series: Lipid Posttranslational Modifications. Protein palmitoylation by a family of DHHC protein S-acyltransferases Published, JLR Papers in Press, April 1, 2006. , 2006, Journal of Lipid Research.
[105] L. Arterburn,et al. Distribution, interconversion, and dose response of n-3 fatty acids in humans. , 2006, The American journal of clinical nutrition.
[106] S. Bandinelli,et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. , 2006, The Journal of clinical endocrinology and metabolism.
[107] T. Kuczek,et al. EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors , 2003, Lipids.
[108] W. Harris. n-3 fatty acids and lipoproteins: Comparison of results from human and animal studies , 1996, Lipids.
[109] B. Holub,et al. Effect of dietary α-linolenic acid and its ratio to linoleic acid on platelet and plasma fatty acids and thrombogenesis , 1993, Lipids.
[110] M. Elia,et al. Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. , 2006, International journal of oncology.
[111] J. Drai,et al. Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. , 2005, The American journal of clinical nutrition.
[112] M. Briel,et al. Effect of different antilipidemic agents and diets on mortality: a systematic review. , 2005, Archives of internal medicine.
[113] Nader Rifai,et al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. , 2005, The Journal of nutrition.
[114] Christoph Handschin,et al. Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1β Coactivation of SREBP , 2005, Cell.
[115] P. Kris-Etherton,et al. Dietary α-Linolenic Acid Reduces Inflammatory and Lipid Cardiovascular Risk Factors in Hypercholesterolemic Men and Women , 2004 .
[116] P. Calder,et al. Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans. , 2004, The American journal of clinical nutrition.
[117] Hee-Yong Kim,et al. Reduced G Protein-coupled Signaling Efficiency in Retinal Rod Outer Segments in Response to n-3 Fatty Acid Deficiency* , 2004, Journal of Biological Chemistry.
[118] P. Calder. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. , 2004, Clinical science.
[119] D. Baer,et al. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. , 2004, The American journal of clinical nutrition.
[120] S. Clarke,et al. Polyunsaturated fatty acids and gene expression , 2004, Current opinion in clinical nutrition and metabolic care.
[121] J. Lau,et al. Effects of omega-3 fatty acids on cardiovascular risk factors and intermediate markers of cardiovascular disease. , 2004, Evidence report/technology assessment.
[122] S. Clarke. The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors , 2004, Current opinion in lipidology.
[123] P. Kris-Etherton,et al. Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. , 2004, The Journal of nutrition.
[124] Shih-Yi Huang,et al. Omega-3 fatty acids in major depressive disorder A preliminary double-blind, placebo-controlled trial , 2003, European Neuropsychopharmacology.
[125] E. Rimm,et al. Habitual Dietary Intake of n-3 and n-6 Fatty Acids in Relation to Inflammatory Markers Among US Men and Women , 2003, Circulation.
[126] J. Pankow,et al. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. , 2003, The American journal of clinical nutrition.
[127] R. Mensink,et al. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. , 2003, The American journal of clinical nutrition.
[128] J. Fernández-Real,et al. Insulin resistance, inflammation, and serum fatty acid composition. , 2003, Diabetes care.
[129] M. Garg,et al. Human Nutrition and Metabolism Research Communication Macadamia Nut Consumption Lowers Plasma Total and LDL Cholesterol Levels in Hypercholesterolemic Men , 2003 .
[130] P. Calder,et al. Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. , 2003, The American journal of clinical nutrition.
[131] P. Calder,et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial , 2003, The Lancet.
[132] N. Espat,et al. NF-kappa B inhibition by omega -3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[133] G. Watts,et al. Docosahexaenoic acid but not eicosapentaenoic acid increases LDL particle size in treated hypertensive type 2 diabetic patients. , 2003, Diabetes care.
[134] Lawrence J Appel,et al. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. , 2003, Circulation.
[135] G. Watts,et al. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. , 2002, The American journal of clinical nutrition.
[136] H. Arnesen,et al. Serum non-esterified very long-chain PUFA are associated with markers of endothelial dysfunction. , 2002, Atherosclerosis.
[137] D. Horrobin,et al. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. , 2002, Archives of general psychiatry.
[138] D. Grobbee,et al. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials , 2002, Journal of hypertension.
[139] P. Yaqoob. Monounsaturated fatty acids and immune function , 2002, European Journal of Clinical Nutrition.
[140] B. Chung,et al. Oleic, linoleic and linolenic acids enhance receptor-mediated uptake of low density lipoproteins in Hep-G2 cells. , 2002, The Journal of nutritional biochemistry.
[141] M. Santini,et al. Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction: Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione , 2002, Circulation.
[142] D. Jump,et al. Dietary polyunsaturated fatty acids and regulation of gene transcription , 2002, Current opinion in lipidology.
[143] C. Schindler,et al. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. , 2002, The American journal of medicine.
[144] R. Belmaker,et al. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. , 2002, The American journal of psychiatry.
[145] B. Puri,et al. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[146] J. Bousquet,et al. Endogenous anti-inflammatory mediators from arachidonate in human neutrophils. , 2002, Biochemical and biophysical research communications.
[147] T. Hamazaki,et al. The Effect of Docosahexaenoic Acid on Aggression in Elderly Thai Subjects—a Placebo-controlled Double-blind Study , 2002, Nutritional neuroscience.
[148] A. Leaf,et al. The Modulation of Ionic Currents in Excitable Tissues by n-3 Polyunsaturated Fatty Acids , 2001, The Journal of Membrane Biology.
[149] F. Dickerson,et al. A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. , 2001, The American journal of psychiatry.
[150] P. Calder,et al. Dietary supplementation with gamma-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans. , 2001, The Journal of nutrition.
[151] S. Rhee,et al. Saturated Fatty Acids, but Not Unsaturated Fatty Acids, Induce the Expression of Cyclooxygenase-2 Mediated through Toll-like Receptor 4* , 2001, The Journal of Biological Chemistry.
[152] G. Vankar,et al. Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia , 2001, Schizophrenia Research.
[153] B. M. Rasmussen,et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study , 2001, Diabetologia.
[154] G. Watts,et al. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. , 2000, The American journal of clinical nutrition.
[155] R. Abbott,et al. Serum lipid effects of a high-monounsaturated fat diet based on macadamia nuts. , 2000, Archives of internal medicine.
[156] Calder,et al. Encapsulated fish oil enriched in α‐tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions , 2000, European journal of clinical investigation.
[157] K. Nagao,et al. Superiority of Dietary Safflower Oil over Olive Oil in Lowering Serum Cholesterol and Increasing Hepatic mRNAs for the LDL Receptor and Cholesterol 7α-Hydroxylase in Exogenously Hypercholesterolemic (ExHC) Rats , 2000, Bioscience, biotechnology, and biochemistry.
[158] GISSI-Prevenzione Investigators,et al. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.
[159] A. Stoll,et al. Omega 3 Fatty Acids in Bipolar Disorder A Preliminary Double-blind, Placebo-Controlled Trial , 1999 .
[160] S. Clarke,et al. Regulation of gene expression by dietary fat. , 1999, Annual review of nutrition.
[161] W. Wahli,et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. , 1997, Molecular endocrinology.
[162] W. Harris,et al. n-3 fatty acids and serum lipoproteins: human studies. , 1997, The American journal of clinical nutrition.
[163] P. Baeuerle,et al. Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid. , 1996, Biochemical and biophysical research communications.
[164] M. Mattson,et al. Linoleic acid activates nuclear transcription factor-kappa B (NF-kappa B) and induces NF-kappa B-dependent transcription in cultured endothelial cells. , 1996, The American journal of clinical nutrition.
[165] T. Hamazaki,et al. The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study. , 1996, The Journal of clinical investigation.
[166] E. Mantzioris,et al. The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. , 1996, The American journal of clinical nutrition.
[167] R. Mensink,et al. Dietary trans fatty acids and lipoprotein cholesterol. , 1995, The American journal of clinical nutrition.
[168] P. Nestel,et al. Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. , 1995, Journal of lipid research.
[169] R W Byard,et al. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. , 1994, The American journal of clinical nutrition.
[170] R. Byard,et al. Fattyacidcompositionofbrain,retina, and erythrocytes in , 1994 .
[171] J. Gordon,et al. Genetic and biochemical studies of protein N-myristoylation. , 1994, Annual review of biochemistry.
[172] F. Sacks,et al. Does Fish Oil Lower Blood Pressure? A Meta‐Analysis of Controlled Trials , 1993, Circulation.
[173] P. Whelton,et al. Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. , 1993, Archives of internal medicine.
[174] J. Besson,et al. Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects. , 1993, Brain : a journal of neurology.
[175] J. Manson,et al. Intake of trans fatty acids and risk of coronary heart disease among women , 1993, The Lancet.
[176] R. Mensink,et al. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[177] J. Gustafsson,et al. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[178] F. Ursini,et al. Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modification. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[179] W. Powell,et al. Formation of monohydroxy derivatives of arachidonic acid, linoleic acid, and oleic acid during oxidation of low density lipoprotein by copper ions and endothelial cells. , 1992, Journal of lipid research.
[180] P. Elwood,et al. EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART) , 1989, The Lancet.
[181] C. von Schacky,et al. Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. , 1985, The Journal of clinical investigation.
[182] M. Crawford,et al. The long chain metabolites of linoleic avid linolenic acids in liver and brain in herbivores and carnivores. , 1976, Comparative biochemistry and physiology. B, Comparative biochemistry.
[183] R. Wells,et al. A preliminary investigation into the oxygen-combining properties of pogonophore haemoglobin. , 1976, Comparative biochemistry and physiology. A, Comparative physiology.